News for 'lupin-pharmaceuticals-inc'

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Rediff.com21 Aug 2020

Baltimore-based Lupin Pharmaceuticals Inc is recalling 5,60,922 pouches of Mibelas 24 Fe (norethindrone acetate and Ethinyl estradiol tablets and ferrous fumarate tablets) in the US, as per the latest enforcement report by the USFDA.

Eli Lilly files suit against Lupin, Aurobindo

Eli Lilly files suit against Lupin, Aurobindo

Rediff.com3 Dec 2008

US-based pharma giants Eli Lilly and company has filed a case against two Indian drug makers, Aurobindo Pharma and Lupin alleging infringement of patent of its anti-depressant drug Cymbalta.

Cornerstone to sell Lupin drug in US

Cornerstone to sell Lupin drug in US

Rediff.com27 Jan 2005

Lupin Pharmaceuticals Inc, the wholly owned subsidiary of Lupin, has entered into an alliance with Cornerstone BioPharma Inc.

Lupin inks pact with Allergan in US

Lupin inks pact with Allergan in US

Rediff.com29 Mar 2004

Lupin Pharmaceuticals Inc, a wholly owned subsidiary of Mumbai-based Lupin Ltd, has forayed into the US pediatric segment by inking an agreement with Allergan Inc to promote 'Zymar' in that country.

Lupin launches generic GERD drug in the US market

Lupin launches generic GERD drug in the US market

Rediff.com11 Nov 2013

The company's US-based subsidiary Lupin Pharmaceuticals Inc has launched its generic Rabeprazole Sodium delayed-release tablets, 20 mg in the American market after having received approval to market it from the US Food and Drug Administration, according to a statement by Lupin.

Lupin launches generic Ciprofloxacin in US market

Lupin launches generic Ciprofloxacin in US market

Rediff.com13 Jun 2014

The company's US subsidiary, Lupin Pharmaceuticals Inc has launched its Ciprofloxacin for oral suspension in the US market in the strengths of 5 g/100 mL (250mg/5 mL) and 10 g/100 mL (500 mg/5 mL), Lupin said in a statement.

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Rediff.com22 Oct 2013

The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.

Nifty ends below 8,700; US jobs data eyed

Nifty ends below 8,700; US jobs data eyed

Rediff.com7 Oct 2016

IT majors weakened ahead of the September US jobs data and telecom stocks ended lower

Markets end at fresh 13-month lows as global stocks derail

Markets end at fresh 13-month lows as global stocks derail

Rediff.com4 Sep 2015

After a volatile session, Sensex closed the day 563 points lower